Schering extends use of Gadovist

Article

The European Union has approved the use of Schering's extracellular agent Gadovist 1.0 for use in MR angiography. Gadovist 1.0 previously had been cleared for contrast-enhanced MR of the brain and spine by EU members and other countries, including the

The European Union has approved the use of Schering's extracellular agent Gadovist 1.0 for use in MR angiography. Gadovist 1.0 previously had been cleared for contrast-enhanced MR of the brain and spine by EU members and other countries, including the U.S. It is the first extracellular contrast agent to receive EU approval for this indication.

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.